Stocks TelegraphStocks Telegraph
Stock Ideas

BIO Stock Analyst Ratings, Estimated Earnings and Price Targets

NYSE : BIO

Bio-Rad Laboratories

$291.17
-4.79-1.62%
Open: 10:59 AM
52.07
B-ESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

BIO Stock 12 Month Analyst Forecast

According to evaluations from 7 analysts over the past year, the consensus analyst rating for BIO stock is "Buy". The average price target based on the past year stands at $320.57, with estimates ranging from $245.00 to $409.00.

Eps Overview

Growth Next 5yrs
8.33%
Last Quarter
$2.26
Past Year
$27.92
Growth Past 5yrs
-26.08%
Next Quarter
$1.97
Estimate Next Year
$0.99

Consensus Rating

Loading...

Consensus Price Target

Highest Price Target

$409.00

41.93% Upside

Mean Price Target

$320.57

11.24% Upside

Lowest Price Target

$245.00

-14.98% Downside

Recent Analyst Ratings

Upgrades, Downgrades, New Coverage

Last Updated On Apr 07, 2026

Actual EPS vs Estimated EPS

BIO Earnings Per Share (EPS) History

According to financial reports, BIO (NYSE: BIO) reported an actual EPS of $2.26 for the quarter ending on Oct 29, 2025, compared to an estimated $2.3, resulting in a -1.74% surprise. In the prior quarter (Jul 31, 2025), BIO recorded an actual EPS of $2.61 with a 35.23% surprise. See BIO's full earnings history.

Earnings History

EPS Surprise Factor Analysis

BIO has experienced notable EPS surprises, with the latest quarter ending Oct 29, 2025 showing a -1.74% miss. Previously, the quarter ending Jul 31, 2025 recorded a 35.23% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.

Report DateActualForecastSurprise Factor
Oct 29, 20252.262.3-1.74%
Jul 31, 20252.611.93+35.23%
May 01, 20252.541.73+46.82%
Feb 13, 20252.92.86+1.40%
Oct 30, 202423.091.16+1,890.52%
Aug 01, 2024-76.262932.12-3,697.31%

After EPS Prices

BIO stock frequently reacts to earnings reports. Following the Oct 29, 2025 earnings, the share price saw a 3.43% rise before closing. On the 7th day after the report, BIO shares recorded a -4.35% decline. Analyze historical BIO stock performance post-earnings.

Earning DateBefore EPS ChangeNext Day Closing Price7th Day Closing Price
Oct 29, 2025$330.42+3.43%$304.61-4.65%$305.56-4.35%
Jul 31, 2025$250.08+3.36%$284.60+17.63%$264.53+9.33%
May 01, 2025$244.08+1.52%$236.34-1.70%$256.68+6.76%
Feb 13, 2025$312.36+1.96%$277.16-9.53%$277.36-9.47%
Oct 30, 2024$331.64+0.32%$358.19+8.35%$369.25+11.70%
Aug 01, 2024$338.36-0.85%$335.93-1.56%$318.41-6.69%

Frequently Asked Questions

Is BIO stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given BIO stock an average recommendation of Buy. 7 analysts have given their ratings to BIO out of which 1 analysts have given strong buy call, 2 analysts have given buy call, 4 analysts rate it hold, 0 analysts advocate strong sell call, and 0 analysts has given sell rating. The average target price of $320.57 gives the stock implied upside of roughly 11.24% over the next year or so.
What have analysts suggested for BIO highest price target?
Analysts suggest BIO's stock price would rise to a high of $409.00.
What is the lowest price target analysts expect for BIO over the next year?
Within the next 12 months, analysts predict the BIO stock price could move to $245.00.
What is the average target price for BIO?
BIO stock has an average analyst estimate of $320.57.
At its current price, how far is BIO from its average target price?
BIO shares are currently trading 11.24% above this price target.
What were BIO’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at $2.26 versus consensus estimates of $2.30, and below the comparable year-ago quarter’s EPS of $23.09.
What are the current estimates for quarterly and annual earnings per share?
BIO's forecasts by analysts estimating quarterly EPS at $1.97 and $0.99 for the whole year.
What has BIO's growth been in the past five years and what is expected in the next five years?
The analysts have projected 8.33% EPS growth for BIO in the next five years, compared to growth rates of -26.08% in the past five years.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings CalendarStocks Watchlist
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph